Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA065761-02
Application #
2108882
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1995-07-11
Project End
1998-06-30
Budget Start
1996-07-01
Budget End
1997-06-30
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Azrak, Rami G; Cao, Shousong; Pendyala, Lakshmi et al. (2007) Efficacy of increasing the therapeutic index of irinotecan, plasma and tissue selenium concentrations is methylselenocysteine dose dependent. Biochem Pharmacol 73:1280-7
Azrak, Rami G; Frank, Cheryl L; Ling, Xiang et al. (2006) The mechanism of methylselenocysteine and docetaxel synergistic activity in prostate cancer cells. Mol Cancer Ther 5:2540-8
Yin, M-B; Li, Z-R; Toth, K et al. (2006) Potentiation of irinotecan sensitivity by Se-methylselenocysteine in an in vivo tumor model is associated with downregulation of cyclooxygenase-2, inducible nitric oxide synthase, and hypoxia-inducible factor 1alpha expression, resulting in reduced angiog Oncogene 25:2509-19
Rustum, Youcef M (2004) Thymidylate synthase: a critical target in cancer therapy? Front Biosci 9:2467-73
Yin, Ming-Biao; Li, Zhan-Rong; Cao, Shousong et al. (2004) Enhanced 7-ethyl-10-hydroxycamptothecin (SN-38) lethality by methylselenocysteine is associated with Chk2 phosphorylation at threonine-68 and down-regulation of Cdc6 expression. Mol Pharmacol 66:153-60
Faessel, Helene M; Slocum, Harry K; Rustum, Youcef M et al. (2003) Thymidine and hypoxanthine protection patterns of the folic acid-enhanced synergies for combinations of trimetrexate plus a polyglutamylatable inhibitor of purine or thymidylate synthesis against human ileocecal HCT-8 cells. Int J Oncol 23:401-9
Tewes, M; Schleucher, N; Achterrath, W et al. (2003) Capecitabine and irinotecan as first-line chemotherapy in patients with metastatic colorectal cancer: results of an extended phase I study. Ann Oncol 14:1442-8
Wu, Jiaxi; Yin, Ming-biao; Hapke, Gunnar et al. (2002) Induction of biphasic DNA double strand breaks and activation of multiple repair protein complexes by DNA topoisomerase I drug 7-ethyl-10-hydroxy-camptothecin. Mol Pharmacol 61:742-8
Yin, Ming-biao; Hapke, Gunnar; Wu, Jiaxi et al. (2002) Chk1 signaling pathways that mediated G(2)M checkpoint in relation to the cellular resistance to the novel topoisomerase I poison BNP1350. Biochem Biophys Res Commun 295:435-44
Hapke, Gunnar; Yin, Ming-Biao; Wu, Jiaxi et al. (2002) Phosphorylation of chk1 at serine-345 affected by topoisomerase I poison SN-38. Int J Oncol 21:1059-66

Showing the most recent 10 out of 41 publications